(Q37696597)

English

Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile (English)

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Clostridium difficile

0 references

1 reference

based on heuristic

inferred from title

whole genome sequencing

1 reference

based on heuristic

inferred from title

1

object named as

David W Eyre

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Ann Sarah Walker

9

object named as

A Sarah Walker

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Derrick W Crook

8

object named as

Derrick W Crook

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

7

object named as

Tim E A Peto

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

David Griffiths

3

object named as

David Griffiths

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Carlos Del Ojo Elias

5

object named as

Carlos Del Ojo Elias

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

author name string

Farah Babakhani

2

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Jaime Seddon

4

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Sherwood L Gorbach

6

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

language of work or name

0 references

publication date

11 November 2013

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

209

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

1446-1451

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

Diverse sources of C. difficile infection identified on whole-genome sequencing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

23 August 2017

Short-term genome stability of serial Clostridium difficile ribotype 027 isolates in an experimental gut model and recurrent human disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

23 August 2017

Detection of mixed infection from bacterial whole genome sequence data allows assessment of its role in Clostridium difficile transmission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

23 August 2017

Microevolutionary analysis of Clostridium difficile genomes to investigate transmission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

23 August 2017

Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

23 August 2017

Predictors of first recurrence of Clostridium difficile infection: implications for initial management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

23 August 2017

Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

23 August 2017

Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

23 August 2017

Fidaxomicin versus vancomycin for Clostridium difficile infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

23 August 2017

Clostridium difficile mixed infection and reinfection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

14 September 2017

Successful treatment of simulated Clostridium difficile infection in a human gut model by fidaxomicin first line and after vancomycin or metronidazole failure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3982846

1 September 2018

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24218500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/INFDIS/JIT598

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37696597&oldid=2139103233"